03/17/2025
4:04 PM | Beryl Capital Management LLC (Filed by)
Checkpoint Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/10/2025
4:24 PM | Checkpoint Therapeutics (Filer)
| Form DEFA14A | |
03/10/2025
6:30 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2025
6:31 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A | |
02/27/2025
3:25 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:38 PM | ARMISTICE CAPITAL, LLC (Filed by)
Checkpoint Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
8:00 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
7:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
8:00 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
8:00 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
4:27 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CKPT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/03/2025
5:26 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SCHEDULE 13D/A | |
12/20/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:32 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:33 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:33 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:30 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:31 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:32 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:00 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2024
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
08/19/2024
4:14 PM | Checkpoint Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/12/2024
3:40 PM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:45 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2024
3:05 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:05 PM | Checkpoint Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/03/2024
7:39 AM | Checkpoint Therapeutics (Filer)
| Form 424B5 | |
07/03/2024
7:44 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
7:00 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:01 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:46 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
8:00 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
8:01 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:05 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/24/2024
3:06 PM | Checkpoint Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/17/2024
4:13 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A | |
05/16/2024
6:33 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:34 PM | Amit Sharma (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:35 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Crypto Market is About to Change Lives (Ad) We’re Opening the Ultimate Crypto Vault…
Don't let this be the missed opportunity you regret for years.
 Claim your FREE book now before it's too late! |
05/16/2024
6:30 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:31 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:32 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
6:30 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:45 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2024
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
04/02/2024
5:00 AM | Checkpoint Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024
5:03 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A | |
03/29/2024
4:03 PM | Checkpoint Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
